Somatostatin is known to mediate its actions through five G-protein-coupled receptors (sst 1 -sst 5 ). We have studied the expression of the sst 1 receptor in the rat hypothalamus by using a subtype-specific antiserum. In Western blotting, the antiserum reacted specifically with a band with an apparent molecular weight of 80,000 in membranes prepared from hypothalamic tissue.
Somatostatin is known to mediate its actions through five G-protein-coupled receptors (sst 1 -sst 5 ). We have studied the expression of the sst 1 receptor in the rat hypothalamus by using a subtype-specific antiserum. In Western blotting, the antiserum reacted specifically with a band with an apparent molecular weight of 80,000 in membranes prepared from hypothalamic tissue.
The localization of the sst 1 receptor was investigated by immunohistochemistry in hypothalamus sections. Additionally, an immunofluorescent double-labeling was performed for the sst 1 receptor and somatostatin. Light microscopy revealed that the sst 1 receptor is located in perikarya and nerve fibers in the rostral periventricular area surrounding the third ventricle as well as in nerve fibers projecting from the perikarya to the external layer of the median eminence. In these neuronal structures, sst 1 immunoreactivity was found to be colocalized with somatostatin. Furthermore, the location of sst 1 receptors was studied by immunoelectron microscopy in the median eminence. In the external layer, receptor immunoreactivity was confined to nerve terminals. Immunoreactive nerve terminals were seen to make synapse-like junctions with other both stained and unstained nerve terminals. Thus, the sst 1 receptor is present in the classic somatostatinergic hypothalamic parvocellular system inhibiting hormone secretion from the anterior pituitary gland. These findings indicate that the sst 1 receptor may act as an autoreceptor and inhibit the release of somatostatin from periventricular neurons projecting to the median eminence.
Key words: somatostatin receptor; sst 1 ; immunohistochemistry; ultrastructure; autoreceptor; hypothalamus; median eminence; synapse From hypothalamic extracts, Brazeau et al. (1973) purified a tetradecapeptide, somatostatin, which was shown to inhibit the release of growth hormone (GH) from the anterior pituitary. Immunohistochemical studies demonstrated that this peptide is located in perikarya in the rostral periventricular area of the third ventricle and is part of the classic parvocellular hypothalamic system (Elde and Parsons, 1975; Hökfelt et al., 1975) . The periventricular somatostatinergic neurons project to the median eminence where somatostatin is released into the hypophyseal portal circulation and carried to the anterior pituitary to inhibit the release of GH, thyroid-stimulating hormone, and prolactin (for review, see Lamberts, 1988) . Somatostatin and GH-releasing hormone (GHRH) act in concert to regulate the pulsatile secretion of GH. In addition to the direct action on the pituitary gland, somatostatin and GHRH have been reported to inhibit their own neurosecretion and also to regulate the secretion of other peptides, thereby indirectly modulating the level of GH release (Lumpkin et al., 1981 (Lumpkin et al., , 1985 for review, see Epelbaum, 1992) .
In addition to playing a neuroendocrine role, somatostatin acts as a neurotransmitter or neuromodulator or both in the CNS, with diverse neurophysiological effects (for review, see Schindler et al., 1996) .
The physiological effects of somatostatin are mediated by highaffinity membrane receptors. Effector mechanisms include the inhibition of adenylyl cyclase and modulation of ion channels and tyrosine phosphatase activity (for review, see Reisine and Bell, 1995) . Five specific membrane receptors for somatostatin (sst 1 -sst 5 ) have been identified by molecular cloning in human and rat (Bruno et al., 1992; Kluxen et al., 1992; Li et al., 1992; Meyerhof et al., 1992; O'Carroll et al., 1992; Yamada et al., 1992a Yamada et al., ,b, 1993 Demchyshyn et al., 1993) .
The distribution of mRNA encoding sst 1 -sst 5 receptors has been investigated in rat and mouse brain by in situ hybridization. The different somatostatin receptor mRNAs are expressed at varying levels in different brain areas (for review, see Schindler et al., 1996) . In two studies, the location of one receptor subtype (sst 2A ) has been described by immunohistochemistry in rat brain (Dournaud et al., 1996; Schindler et al., 1997) .
We have raised specific antibodies against the C-terminal part of the sst 1 receptor. In this study, we show by use of doubleimmunofluorescent labeling the presence of the sst 1 receptor in the parvocellular somatostatin-containing neurons projecting from the hypothalamic periventricular nucleus to the median eminence. By immunocytochemistry at the electron microscopical level, immunoreactive terminals in the median eminence are shown to make presynaptic contacts with other nerve terminals.
MATERIALS AND METHODS
Immunoblot. Male Wistar rats weighing 180 gm were anesthetized by intraperitoneal injection of tribromethanol (400 mg / kg) and killed by decapitation. The hypothalamic areas were dissected out and homogenized in buffer 1 (50 mM Tris base, 1 mM EGTA, 5 mM MgC l 2 , pH 7.4; supplemented with proteinase inhibitors bacitracin 200 g /ml, leupeptin 2 g /ml, phenylmethylsulfonyl fluoride 100 g /ml). The homogenate was pelleted and rehomogenized in buffer 1. Protein concentrations were determined using a Bio-Rad (Hercules, CA) protein assay kit.
T wenty-five micrograms of membrane protein were reduced with 2-mercaptoethanol and fractionated in SDS-PAGE (12%). Electrophoresed proteins were semi-dry-blotted onto nitrocellulose membranes. The blots were saturated with 5% w/ v defatted dry milk in TBS (50 mM Tris-HC l, 150 mM NaC l, pH 7.5) containing 0.1% T ween 20 (TBS-T) for 1 hr at room temperature and reacted with anti-sst 1 antiserum diluted 1:1000 in 5% dry milk in TBS-T for 1 hr at room temperature. Immunoreactive bands were visualized by incubation with horseradish peroxidase-conjugated swine anti-rabbit IgG (Dako, Glostrup, Denmark) at 1:2000 for 1 hr at room temperature and detected by enhanced chemiluminescence (Amersham, Little Chalfont, UK). As a control, the antiserum was preabsorbed overnight at 4°C with 50 g f usion protein /ml diluted serum.
T issue preparation. For light microscopical immunohistochemistry, adult male Wistar rats weighing 250 gm were anesthetized by intraperitoneal injection of tribromethanol (400 mg / kg) and fixed by vascular perf usion with 4% cold paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 15 min. The brains were removed, post-fixed overnight in the same fixative, and transferred to PBS. Brains were cryoprotected in 30% sucrose in PBS, sectioned into 40-m-thick cryostat sections, and transferred to PBS.
Immunohistochemistr y. All reactions were performed on free-floating coronal sections. Endogenous peroxidase activity was quenched by incubating the sections in 1% H 2 O 2 in PBS. This was followed by a 20 min preincubation with 5% normal swine serum and 1% BSA in PBS/0.3% Triton X-100. Sections were incubated overnight at 4°C with an anti-sst 1 antiserum diluted 1:10,000 in PBS/1%BSA /0.3% Triton X-100. This antiserum was raised in rabbit against the C -terminal part of the human sst 1 receptor expressed as f usion proteins with glutathione S-transferase. The antiserum was shown not to cross-react with any of the other somatostatin receptor subtypes (Helboe et al., 1997) .
The sections were incubated for 1 hr with biotinylated swine antirabbit immunoglobulins (Dako) at 1:500 followed by 45 min with horseradish peroxidase-conjugated streptavidin -biotin complex (strept-ABC) (Dako). Biotinylated tyramide (DuPont N EN, Boston, M A) was applied to the sections at 1:50 for 10 min, and sections were finally incubated an additional 45 min with strept-ABC. Immunoreactivity was visualized with 0.05% diaminobenzidine (DAB) and 0.01% H 2 O 2 . The sections were mounted on glass slides using 0.5% gelatin in distilled water and then air-dried and coverslipped with Depex.
For controls, the diluted antiserum was preabsorbed with 50 g sst 1 f usion protein /ml overnight at 4°C before incubation of the sections. Double-immunofluorescent labeling. For double-visualization of sst 1 and somatostatin immunoreactivity, sections were incubated overnight at 4°C with anti-sst 1 antiserum at 1:10,000 and anti-somatostatin antibody raised in sheep (American Research Products, Belmont, M A) diluted to 20 g /ml. This was followed by incubation with biotinylated anti-rabbit antibodies 1:500, strept-ABC, and biotinylated tyramide 1:50 (as described above). The sections were then incubated with streptavidin fluorescein (Amersham) at 1:50 and Texas Red-conjugated donkey antisheep IgG (Jackson ImmunoResearch, West Grove, PA) at 1:100. The sections were mounted on glass slides with fluorescent mounting medium (Dako) and examined in the light microscope equipped with an epifluorescence system. Identical fields of sections were photographed for the two fluorescent markers.
To test for possible cross-reactions between primary and secondary antibodies, control sections were first incubated with either anti-sst 1 antiserum or anti-somatostatin antibodies. Incubation with each of the primary antibodies was followed by biotinylated antibodies, strept-ABC, and biotinylated tyramide. The unrelated fluorescent marker was then added to the sections, i.e., Texas Red-conjugated donkey anti-sheep IgG to sections with the anti-sst 1 antiserum and streptavidin fluorescein to sections with the anti-somatostatin antibody.
Immunoc ytochemistr y. For ultrastructural localization of sst 1 immunoreactivity in the median eminence, male Wistar rats weighing 250 gm were anesthetized and perf used with 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer. The brains were removed, post-fixed overnight in the same fixative, and transferred to PBS. Coronal sections (100-m-thick) of the hypothalamus, including the median eminence, were cut on a vibratome. Before the immunoreaction, the sections were treated with 1% sodium borohydride and 0.1% sodium periodate in PBS for 45 min, cryoprotected in 20% sucrose, and snap-frozen in liquid nitrogen. Immunolabeling was performed as described above (see Immunohistochemistry) except that the anti-sst 1 antiserum was 1:1000. The signal was visualized with DAB. The sections were post-fixed for 1 hr in 2% osmium tetroxide, dehydrated, and embedded in Epon. Thin sections with a gray to silver interference color were cut on a Reichert ultratome and contrasted with lead citrate. The sections were examined and photographed in a Philips EM208 electron microscope operated at 60 kV.
Thin sections of material in which the immunocytochemical staining was omitted served as controls.
RESULTS Immunoblot
To establish whether the anti-sst 1 antiserum recognizes the sst 1 receptor in hypothalamic tissue, we performed Western blot analysis on membrane preparations from rat hypothalamus. Immunoreaction with the anti-sst 1 antiserum resulted in a major band of an apparent molecular weight of ϳ80,000 (Fig. 1) . This immunoreaction was abolished when the antiserum was preabsorbed with the sst 1 antigen before the reaction.
Immunohistochemistry
Strongly stained perikarya and nerve fibers positive for sst 1 were detected with DAB visualization in the periventricular area of the hypothalamus and the median eminence. In control sections where the antiserum had been preabsorbed with the sst 1 antigen before the immunoreaction, this staining was abolished completely (data not shown).
In the area surrounding the third ventricle, many sst 1 -immunoreactive perikarya and fibers with boutons en passage were observed. This immunostaining was limited to the rostral part of the periventricular nucleus from the organum vasculosum laminae terminalis extending caudally to the rostral part of the median eminence (Fig. 2) . Some perikarya and nerve fibers were located within the ependymal and subependymal layers adjacent to the third ventricle (Fig. 2 E) . In the median eminence, a strong staining was observed in the external layer over the entire length of the structure (Fig. 3) . The immunoreactivity was confined to nerve fibers endowed with large swellings. The fibers were located mainly around the portal capillaries.
A medium-strong immunoreactivity was observed in fibers throughout the suprachiasmatic nucleus (Fig. 2 B) . No stained perikarya were detected in this structure. Single perikarya and nerve fibers were occasionally observed scattered in the cortex and hypothalamus (Fig. 2 D) .
Double-immunofluorescent labeling
With the fluorescent detection system using fluorescein and Texas Red, a widespread labeling of both sst 1 and somatostatinimmunoreactive neuronal structures was observed. There was no cross-reactivity between the anti-sst 1 antiserum and the Texas Red fluorescent marker, or between the anti-somatostatin antibody and the streptavidin fluorescein (not shown).
Compared with the DAB detection system, fewer perikarya were marked by using fluorescent markers. However, the number of positive nerve fibers was generally the same. This may reflect a less abundant signal for sst 1 in perikarya compared with fibers; thus it was not detected in a less sensitive fluorescent visualization.
The largest concentration of labeled structures was located in the periventricular nucleus and the external part of the median eminence. There was an extensive colocalization of sst 1 and Figure 4 . Double-immunofluorescent labeling of the rat median eminence. sst 1 is visualized by fluorescein ( green) and somatostatin with Texas Red (red). A strong labeling was observed in the external layer for sst 1 ( A) and somatostatin ( B). A double-exposure micrograph is shown ( C) displaying colocalization of somatostatin and sst 1 . Arrows mark the border between the internal and external layers of the median eminence. Double-exposure micrograph of high magnification of the median eminence ( D) shows nerve fibers with boutons containing both sst 1 and somatostatin (arrowheads) or somatostatin alone (arrows). itl marks the position of the internal layer. A periventricular nerve fiber endowed with large boutons shows colocalization of sst 1 ( E) and somatostatin ( F ). Note the perikaryon exhibiting a positive immunoreaction for somatostatin (arrow) but not for sst 1 somatostatin immunoreactivity (Fig. 4) . Some somatostatinpositive perikarya and fibers did not contain sst 1 immunoreactivity (Fig. 4 D-F) , whereas no sst 1 was detected outside somatostatinergic perikarya or fibers.
Ultrastructural immunocytochemistry
Thin sections of the median eminence showed the sst 1 immunoreactivity to be confined to the nerve terminals located predominantly in the external layer of the median eminence (Fig. 5A) . The number of immunoreactive terminals was roughly estimated to be below 5% of the total number of boutons. Perikarya in the median eminence were never stained. Nonreactive nerve fibers could be observed to terminate in positive-stained nerve terminals (Fig. 5B) .
The immunoreactive terminals contained both 20 -40 nm clear transmitter vesicles and larger 100 -300 nm dense-core vesicles (Fig. 6) .
The immunoreactive terminals often made presynaptic contacts with unstained nerve terminals containing small clear and single large dense-core vesicles (Fig. 6C,D) . Sometimes two positive nerve terminals were observed to be connected by synapse-like junctions (Fig. 6 A) . Positive terminals also made synaptic contacts with neuronal perikarya in the median eminence (Fig. 6 B) .
DISCUSSION
In Western blotting, the anti-sst 1 antiserum specifically recognized a band in preparations of membranes isolated from rat hypothalamic tissue. The 80,000 apparent molecular weight band detected in the hypothalamus is larger than a broad band centered around 63,000 that was observed previously in BHK cells transfected with the human sst 1 receptor (Helboe et al., 1997) . This may reflect differences in the pattern of post-translational modifications between BHK cell lines and hypothalamic cells, including varying degrees of phosphorylation and glycosylation.
Retrograde neuronal tracings combined with immunohistochemical detection of somatostatin have shown that somatostatincontaining nerve fibers projecting to the median eminence originate in somatostatinergic perikarya in the hypothalamic periventricular region (Ishikawa et al., 1987; Kawano and Daikoku, 1988; Romero and Phelps, 1997) . In the present study, we show that sst 1 receptors are abundantly present in this neuronal projection system, on the perikarya as well as on the nerve fibers projecting from these perikarya to the external layer of the median eminence. This is in accordance with previous findings by in situ hybridization in the rat and mouse where mRNA encoding the sst 1 receptor was found in periventricular-located perikarya (Breder et al., 1992; Pérez et al., 1994; Beaudet et al., 1995; Guo et al., 1996) .
The double-labelings performed in this study revealed that sst 1 -immunoreactive neurons also contained somatostatin. This colocalization indicates that the sst 1 receptor acts as an autoreceptor. Several studies suggest that somatostatin is able to inhibit its own secretion. Thus, intraventricular injection of somatostatin induced a paradoxical increase in the plasma concentration of GH (Abe et al., 1978; Lumpkin et al., 1981) , and somatostatin or its analogs have been shown to suppress somatostatin release in cultured hypothalamic cells (Peterfreund and Vale, 1984; Richardson and Twente, 1986) and in anterior periventricular tissues (Epelbaum et al., 1986) .
Somatostatin is present in the CSF (Patel et al., 1977) , from which the peptide can diffuse into the periventricular neuropil where the somatostatin-containing perikarya are located. This is possible because the ependymal cells of the third ventricle are connected by gap and intermediate junctions (Brightman and Reese, 1969; Weindl and Joynt, 1972 ) that do not obstruct the diffusion of somatostatin from the ventricle into the brain. However, in the region of the median eminence, tight junctions connect the ependymal cells (Weindl and Joynt, 1972; Krisch and Leonhardt, 1978) , preventing a diff usion directly into the brain parenchyma of this region. The presence of this barrier will create a considerable time delay for somatostatin action on nerve terminals in the median eminence. Therefore, one might speculate that somatostatin in the C SF may not bind to the autoreceptors on the somatostatinergic nerve terminals in this region to cause an increase in GH level but more likely may mediate this effect via binding to periventricular somatostatinergic neurons. In contrast, an ultrashort loop of inhibitory feedback may be present in the median eminence. Somatostatin released into the extracellular space may bind to sst 1 receptors on the same terminal from which somatostatin is released and thus inhibit further release of the hormone.
The ultrastructural analysis of the median eminence in this study showed the sst 1 receptor to be confined to nerve terminals. Because of diffusion of the DAB reaction product, the receptor protein could not be localized to any cellular compartment or 
